Burkitt Lymphoma Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: BD9123A6E24EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Burkitt Lymphoma Treatment in Global, including the following market information:

Global Burkitt Lymphoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Burkitt Lymphoma Treatment market was valued at 728.9 million in 2021 and is projected to reach US$ 856.1 million by 2028, at a CAGR of 2.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ARV-825 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Burkitt Lymphoma Treatment include AbbVie Inc, Arvinas, Inc., bluebird bio, Inc., Boehringer Ingelheim GmbH, Constellation Pharmaceuticals, Inc., Immunomedics, Inc., Karyopharm Therapeutics, Inc., Millennium Pharmaceuticals Inc and Patrys Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Burkitt Lymphoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Burkitt Lymphoma Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Burkitt Lymphoma Treatment Market Segment Percentages, by Type, 2021 (%)

• ARV-825
• Alisertib
• BB-2121
• Ibrutinib
• Others

Global Burkitt Lymphoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Burkitt Lymphoma Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Burkitt Lymphoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Burkitt Lymphoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Burkitt Lymphoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Burkitt Lymphoma Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie Inc
• Arvinas, Inc.
• bluebird bio, Inc.
• Boehringer Ingelheim GmbH
• Constellation Pharmaceuticals, Inc.
• Immunomedics, Inc.
• Karyopharm Therapeutics, Inc.
• Millennium Pharmaceuticals Inc
• Patrys Limited
• Seattle Genetics, Inc.
• Takeda Pharmaceutical Company Limited
• Theravectys SA

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Burkitt Lymphoma Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Burkitt Lymphoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BURKITT LYMPHOMA TREATMENT OVERALL MARKET SIZE

2.1 Global Burkitt Lymphoma Treatment Market Size: 2021 VS 2028
2.2 Global Burkitt Lymphoma Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Burkitt Lymphoma Treatment Players in Global Market
3.2 Top Global Burkitt Lymphoma Treatment Companies Ranked by Revenue
3.3 Global Burkitt Lymphoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Burkitt Lymphoma Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Burkitt Lymphoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Burkitt Lymphoma Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Burkitt Lymphoma Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Burkitt Lymphoma Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Burkitt Lymphoma Treatment Market Size Markets, 2021 & 2028
  4.1.2 ARV-825
  4.1.3 Alisertib
  4.1.4 BB-2121
  4.1.5 Ibrutinib
  4.1.6 Others
4.2 By Type - Global Burkitt Lymphoma Treatment Revenue & Forecasts
  4.2.1 By Type - Global Burkitt Lymphoma Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Burkitt Lymphoma Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Burkitt Lymphoma Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Burkitt Lymphoma Treatment Revenue & Forecasts
  5.2.1 By Application - Global Burkitt Lymphoma Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Burkitt Lymphoma Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Burkitt Lymphoma Treatment Market Size, 2021 & 2028
6.2 By Region - Global Burkitt Lymphoma Treatment Revenue & Forecasts
  6.2.1 By Region - Global Burkitt Lymphoma Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Burkitt Lymphoma Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Burkitt Lymphoma Treatment Revenue, 2017-2028
  6.3.2 US Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.3.3 Canada Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.3.4 Mexico Burkitt Lymphoma Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Burkitt Lymphoma Treatment Revenue, 2017-2028
  6.4.2 Germany Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.4.3 France Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.4.4 U.K. Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.4.5 Italy Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.4.6 Russia Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.4.8 Benelux Burkitt Lymphoma Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Burkitt Lymphoma Treatment Revenue, 2017-2028
  6.5.2 China Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.5.3 Japan Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.5.4 South Korea Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.5.6 India Burkitt Lymphoma Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Burkitt Lymphoma Treatment Revenue, 2017-2028
  6.6.2 Brazil Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.6.3 Argentina Burkitt Lymphoma Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Burkitt Lymphoma Treatment Revenue, 2017-2028
  6.7.2 Turkey Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.7.3 Israel Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Burkitt Lymphoma Treatment Market Size, 2017-2028
  6.7.5 UAE Burkitt Lymphoma Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie Inc
  7.1.1 AbbVie Inc Corporate Summary
  7.1.2 AbbVie Inc Business Overview
  7.1.3 AbbVie Inc Burkitt Lymphoma Treatment Major Product Offerings
  7.1.4 AbbVie Inc Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Inc Key News
7.2 Arvinas, Inc.
  7.2.1 Arvinas, Inc. Corporate Summary
  7.2.2 Arvinas, Inc. Business Overview
  7.2.3 Arvinas, Inc. Burkitt Lymphoma Treatment Major Product Offerings
  7.2.4 Arvinas, Inc. Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.2.5 Arvinas, Inc. Key News
7.3 bluebird bio, Inc.
  7.3.1 bluebird bio, Inc. Corporate Summary
  7.3.2 bluebird bio, Inc. Business Overview
  7.3.3 bluebird bio, Inc. Burkitt Lymphoma Treatment Major Product Offerings
  7.3.4 bluebird bio, Inc. Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.3.5 bluebird bio, Inc. Key News
7.4 Boehringer Ingelheim GmbH
  7.4.1 Boehringer Ingelheim GmbH Corporate Summary
  7.4.2 Boehringer Ingelheim GmbH Business Overview
  7.4.3 Boehringer Ingelheim GmbH Burkitt Lymphoma Treatment Major Product Offerings
  7.4.4 Boehringer Ingelheim GmbH Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.4.5 Boehringer Ingelheim GmbH Key News
7.5 Constellation Pharmaceuticals, Inc.
  7.5.1 Constellation Pharmaceuticals, Inc. Corporate Summary
  7.5.2 Constellation Pharmaceuticals, Inc. Business Overview
  7.5.3 Constellation Pharmaceuticals, Inc. Burkitt Lymphoma Treatment Major Product Offerings
  7.5.4 Constellation Pharmaceuticals, Inc. Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.5.5 Constellation Pharmaceuticals, Inc. Key News
7.6 Immunomedics, Inc.
  7.6.1 Immunomedics, Inc. Corporate Summary
  7.6.2 Immunomedics, Inc. Business Overview
  7.6.3 Immunomedics, Inc. Burkitt Lymphoma Treatment Major Product Offerings
  7.6.4 Immunomedics, Inc. Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.6.5 Immunomedics, Inc. Key News
7.7 Karyopharm Therapeutics, Inc.
  7.7.1 Karyopharm Therapeutics, Inc. Corporate Summary
  7.7.2 Karyopharm Therapeutics, Inc. Business Overview
  7.7.3 Karyopharm Therapeutics, Inc. Burkitt Lymphoma Treatment Major Product Offerings
  7.7.4 Karyopharm Therapeutics, Inc. Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.7.5 Karyopharm Therapeutics, Inc. Key News
7.8 Millennium Pharmaceuticals Inc
  7.8.1 Millennium Pharmaceuticals Inc Corporate Summary
  7.8.2 Millennium Pharmaceuticals Inc Business Overview
  7.8.3 Millennium Pharmaceuticals Inc Burkitt Lymphoma Treatment Major Product Offerings
  7.8.4 Millennium Pharmaceuticals Inc Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.8.5 Millennium Pharmaceuticals Inc Key News
7.9 Patrys Limited
  7.9.1 Patrys Limited Corporate Summary
  7.9.2 Patrys Limited Business Overview
  7.9.3 Patrys Limited Burkitt Lymphoma Treatment Major Product Offerings
  7.9.4 Patrys Limited Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.9.5 Patrys Limited Key News
7.10 Seattle Genetics, Inc.
  7.10.1 Seattle Genetics, Inc. Corporate Summary
  7.10.2 Seattle Genetics, Inc. Business Overview
  7.10.3 Seattle Genetics, Inc. Burkitt Lymphoma Treatment Major Product Offerings
  7.10.4 Seattle Genetics, Inc. Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.10.5 Seattle Genetics, Inc. Key News
7.11 Takeda Pharmaceutical Company Limited
  7.11.1 Takeda Pharmaceutical Company Limited Corporate Summary
  7.11.2 Takeda Pharmaceutical Company Limited Business Overview
  7.11.3 Takeda Pharmaceutical Company Limited Burkitt Lymphoma Treatment Major Product Offerings
  7.11.4 Takeda Pharmaceutical Company Limited Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.11.5 Takeda Pharmaceutical Company Limited Key News
7.12 Theravectys SA
  7.12.1 Theravectys SA Corporate Summary
  7.12.2 Theravectys SA Business Overview
  7.12.3 Theravectys SA Burkitt Lymphoma Treatment Major Product Offerings
  7.12.4 Theravectys SA Burkitt Lymphoma Treatment Revenue in Global Market (2017-2022)
  7.12.5 Theravectys SA Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Burkitt Lymphoma Treatment Market Opportunities & Trends in Global Market
Table 2. Burkitt Lymphoma Treatment Market Drivers in Global Market
Table 3. Burkitt Lymphoma Treatment Market Restraints in Global Market
Table 4. Key Players of Burkitt Lymphoma Treatment in Global Market
Table 5. Top Burkitt Lymphoma Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Burkitt Lymphoma Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Burkitt Lymphoma Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Burkitt Lymphoma Treatment Product Type
Table 9. List of Global Tier 1 Burkitt Lymphoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Burkitt Lymphoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Burkitt Lymphoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Burkitt Lymphoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Burkitt Lymphoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Burkitt Lymphoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Burkitt Lymphoma Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Burkitt Lymphoma Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Inc Corporate Summary
Table 31. AbbVie Inc Burkitt Lymphoma Treatment Product Offerings
Table 32. AbbVie Inc Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Arvinas, Inc. Corporate Summary
Table 34. Arvinas, Inc. Burkitt Lymphoma Treatment Product Offerings
Table 35. Arvinas, Inc. Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 36. bluebird bio, Inc. Corporate Summary
Table 37. bluebird bio, Inc. Burkitt Lymphoma Treatment Product Offerings
Table 38. bluebird bio, Inc. Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Boehringer Ingelheim GmbH Corporate Summary
Table 40. Boehringer Ingelheim GmbH Burkitt Lymphoma Treatment Product Offerings
Table 41. Boehringer Ingelheim GmbH Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Constellation Pharmaceuticals, Inc. Corporate Summary
Table 43. Constellation Pharmaceuticals, Inc. Burkitt Lymphoma Treatment Product Offerings
Table 44. Constellation Pharmaceuticals, Inc. Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Immunomedics, Inc. Corporate Summary
Table 46. Immunomedics, Inc. Burkitt Lymphoma Treatment Product Offerings
Table 47. Immunomedics, Inc. Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Karyopharm Therapeutics, Inc. Corporate Summary
Table 49. Karyopharm Therapeutics, Inc. Burkitt Lymphoma Treatment Product Offerings
Table 50. Karyopharm Therapeutics, Inc. Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Millennium Pharmaceuticals Inc Corporate Summary
Table 52. Millennium Pharmaceuticals Inc Burkitt Lymphoma Treatment Product Offerings
Table 53. Millennium Pharmaceuticals Inc Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Patrys Limited Corporate Summary
Table 55. Patrys Limited Burkitt Lymphoma Treatment Product Offerings
Table 56. Patrys Limited Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Seattle Genetics, Inc. Corporate Summary
Table 58. Seattle Genetics, Inc. Burkitt Lymphoma Treatment Product Offerings
Table 59. Seattle Genetics, Inc. Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Takeda Pharmaceutical Company Limited Corporate Summary
Table 61. Takeda Pharmaceutical Company Limited Burkitt Lymphoma Treatment Product Offerings
Table 62. Takeda Pharmaceutical Company Limited Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Theravectys SA Corporate Summary
Table 64. Theravectys SA Burkitt Lymphoma Treatment Product Offerings
Table 65. Theravectys SA Burkitt Lymphoma Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Burkitt Lymphoma Treatment Segment by Type in 2021
Figure 2. Burkitt Lymphoma Treatment Segment by Application in 2021
Figure 3. Global Burkitt Lymphoma Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Burkitt Lymphoma Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Burkitt Lymphoma Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Burkitt Lymphoma Treatment Revenue in 2021
Figure 8. By Type - Global Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 12. US Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 24. China Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Burkitt Lymphoma Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Burkitt Lymphoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Inc Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Arvinas, Inc. Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. bluebird bio, Inc. Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boehringer Ingelheim GmbH Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Constellation Pharmaceuticals, Inc. Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Immunomedics, Inc. Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Karyopharm Therapeutics, Inc. Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Millennium Pharmaceuticals Inc Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Patrys Limited Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Seattle Genetics, Inc. Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Takeda Pharmaceutical Company Limited Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Theravectys SA Burkitt Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)